Intraperitoneal administration of fosfomycin, metronidazole, and granulocyte-macrophage colony-stimulating factor in patients undergoing appendectomy is safe: a phase II clinical trial

We aimed to investigate the safety of intraperitoneal administration of the combination of fosfomycin, metronidazole, and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in patients undergoing appendectomy. We conducted a prospective phase II clinical trial in 14 otherw...

Descripción completa

Detalles Bibliográficos
Autores principales: Fonnes, Siv, Holzknecht, Barbara Juliane, Arpi, Magnus, Rosenberg, Jacob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491470/
https://www.ncbi.nlm.nih.gov/pubmed/31040341
http://dx.doi.org/10.1038/s41598-019-43151-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491470/
https://www.ncbi.nlm.nih.gov/pubmed/31040341
http://dx.doi.org/10.1038/s41598-019-43151-4

Ejemplares similares